We investigated the PFS according to the mutation in pathways frequently mutated in HCC patients, such as PI3K/MTOR pathway, WNT pathway, chromatin remodeling, cell cycle control and telomere maintenance. The gene discussed is MTOR; the disease is hepatocellular carcinoma.